Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
For example, GLP-1 is a peptide hormone that inhibits glucagon secretion , reduces appetite , and promotes insulin production
Heres how they differ from other approaches : Oral supplements : Lower bioavailability than injections, but useful for maintenance
AOD-9604 can be administered via subcutaneous injection or orally, depending on the formulation available
The usual dose is 5ml per 100lbs of body weight